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Abstract
To consider the evidence that human and animal behaviours are epigeneti-
cally programmed by lifetime experiences. Extensive PubMed searches
were carried out to gain a broad view of the topic, in particular from the
perspective of human psychopathologies such as mood and anxiety disor-
ders. The selected literature cited is complemented by previously unpub-
lished data from the authors’ laboratories. Evidence that physiological and
behavioural functions are particularly sensitive to the programming effects
of environmental factors such as stress and nutrition during early life, and
perhaps at later stages of life, is reviewed and extended. Definition of stim-
ulus- and function-specific critical periods of programmability together
with deeper understanding of the molecular basis of epigenetic regulation
will deliver greater appreciation of the full potential of the brain’s plastic-
ity while providing evidence-based social, psychological and pharmacologi-
cal interventions to promote lifetime well-being.
Keywords adolescent obesity, behaviour, early life stress, epigenetics,
psychopathology.
The future is now. From conception onwards, our
physical and social environments trigger a series
of biochemical, morphological and physiological
responses that act on the genetic blueprint to adjust
development and lifelong programs of somatic and
mental function. This continuous gene–environment
dialogue can lead to persistent ‘anticipatory’ changes
in the phenotype. This essential process is frequently
referred to as ‘programming’ and allows the organ-
ism to make homoeostatic adaptations (including
resetting of physiological sensors and thresholds) that
ensure compatibility with changing environments and
demands and therefore survival. In some cases, how-
ever, programming may result in maladaptation due
to inherent (genetic) constraints, asynchronous or
exaggerated adjustments in the chain of responses
leading to elicitation of an overt physiological or
behavioural output, or inflexibility induced by a pre-
ceding (programming) event. Epigenetic mechanisms –
involving methylation or hydroxymethylation of DNA
[at cytosine–phosphate–guanine dinucleotide sites
(CpG)] or post-translational chromatin modification
(histone acetylation, methylation, ubiquitination,
phosphorylation, sumoylation) – are emerging as a
powerful way to explain long-term (or even lifetime)
programming and reprogramming of phenotype. Other
authors have provided comprehensive reviews of the
mechanisms underlying the genome–environment
dialogue and determination of phenotype (Meaney
2010, Hoffmann & Spengler 2012, Baker-Andresen
et al. 2013, Hunter & McEwen 2013).
The term ‘epigenome’ refers to the ensemble of
coordinated epigenetic marks that govern accessibility
of the machinery driving gene expression to DNA.
Specific histone modifications and DNA methylation
reciprocally control each other’s deposition whereby
inaccessible genes are silenced and accessible ones can
be actively transcribed. Importantly, epigenetic modifi-
cations such as DNA methylation do not alter the
genetic sequence itself but control the accessibility of
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regulatory factors to the control regions of genes.
Chromatin remodelling by histone modifications is
generally considered to be reversible, allowing tran-
sient adaptations in physiology and behaviour. On the
other hand, DNA methylation results in more stable,
if not irreversible, changes that manifest themselves in
long-term altered patterns of gene expression, often
interpreted as the encoding of ‘memories’ into genes.
It is important to emphasize at the outset, however,
that epigenetic alterations in gene activity occur in a
dynamic (sometimes transient) fashion (see Ptashne
2013). Not every stimulus necessarily evokes an epige-
netic adjustment, even though the overall response
may be influenced by previous (epigenetic trace leav-
ing) experience. Interestingly, DNA methylation does
not occur in all organisms (e.g. flies, worms); yet, all
organisms survive by making immediate (acute) bio-
chemical and physiological responses to multitudinal
challenges received on a time scale ranging from milli-
seconds to hours or days, by primarily exploiting their
genetically determined cellular hardware.
The epigenetic dimension of neuroplasticity
Epigenetic programming plays an important role in
cancer but also in the regulation of the physiology
and pathology of other proliferating cells. Although
the view that memory could be encoded in DNA more
than 40 years ago (Griffith & Mahler 1969), the idea
that postmitotic neurones have the potential to be epi-
genetically programmed by experience (learning)
gained broad currency only in the last few years.
The developing brain is highly plastic during gesta-
tion and early postnatal life (Toga et al. 2006). It is
estimated that the embryonic human brain grows by
some 250 000 new cells per minute (Cowan 1979)
that eventually organize themselves into functional
units. During the last trimester of pregnancy, synapses
are formed at the rate of 40 000 min1 (Bourgeois
1997), and efficient transmission is ensured through
myelination of axons. However, suggestions that the
existence of windows (‘sensitive’ or ‘critical’ periods),
during puberty and perhaps even beyond, when the
architecture of the brain is reorganized in response to
changing environments, is supported by neuroimaging
studies that have revealed the dynamic growth and
functional connectivity (during the first 2 years); also
to be noted is that neurons in the human brain
undergo extensive pruning and reorganization from
early postnatal life right through early adulthood, but
especially during puberty (Huttenlocher & Dabholkar
1997, Levitt 2003, Knickmeyer et al. 2008, Gao et al.
2011, Jernigan et al. 2011). Moreover, it is now
known that certain brain regions can produce new
neurones even in adulthood (Eriksson et al. 1998,
Kempermann 2012), expanding the plastic potential
of the brain in terms of connections and incorporation
of new epigenetic information (Ma et al. 2010,
Castren & Hen 2013, Mateus-Pinheiro et al. 2013).
Thus, experiential memories can be laid down through
epigenetic marking (DNA and histone memories) and/
or histomorphological adaptations (structural memo-
ries).
There is accumulating evidence that programming
of physiological and behavioural functions is not lim-
ited to the intra-uterine or neonatal period. For exam-
ple, recent studies show that adolescence and puberty,
as well as adulthood, represent permissive windows
for programming by stress (Lupien et al. 2009,
Beardslee et al. 2012, Hunter & McEwen 2013) and
nutritional status (Pervanidou & Chrousos 2012) in
rodents and non-human primates. Conditions such as
stress and obesity, on the one hand, and obesity and
mental well-being, on the other, appear to be interde-
pendent (Dauncey 2013, Sinha & Jastreboff 2013);
accordingly, it will be interesting to tease apart the
contribution of the individual stimuli to the program-
ming of physiology and behaviour. Other open ques-
tions concern how social history and the social
context in which exposure occurs factor into the
complex equation that defines phenotype, in particular
psychopathological phenotypes (see Rutter 2012),
and the mechanisms through which epigenetic pro-
grams are apparently transmitted across generations
(Bohacek et al. 2012). Recently, Keverne (2013) sug-
gested that the mechanisms that predispose an individ-
ual to epigenetic changes, rather than parental
adaptations, can be transferred to subsequent genera-
tions (cf. Niwa et al. 2013).
Adverse lifetime events and mental health
Developmental psychobiologists have long been inter-
ested in the ‘Nature vs. Nurture’ question (for a com-
prehensive review, see Sameroff 2010). This area has
recently generated much interest in psychiatry and
neurology with growing recognition that historical
(lifetime) events can have an impact on the etiopatho-
genesis of mood, affective and cognitive disorders
(Tsankova et al. 2007, Lupien et al. 2009). For
instance, trauma during childhood correlates with risk
of developing anxiety and major depression in adult-
hood (Heim & Binder 2012), and parent–infant
relationships are reflected in executive functioning
(Bernier et al. 2010, Hedges & Woon 2011);
similarly, early life adversity is associated with signifi-
cant cognitive and emotional impairments in mice
(Murgatroyd et al. 2009, Meaney 2010).
The above observations illustrate that brain health,
like somatic health (Gluckman & Hanson 2004, Wells
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2007, Hanson & Gluckman 2011), is subject to
adaptive programming induced by environmental cues.
Notably, an authoritative policy paper observed that
the ‘mental wealth of nations’ can be potentially
improved by considering improvements in the social,
economic health and educational environment that
individuals are exposed to over the whole lifespan
(Beddington et al. 2008), findings echoed in other
studies (Duncan et al. 2010, Santos et al. 2012). Fur-
ther, it is important to note that lifetime events do not
necessarily leave an irreversible imprint on the brain.
This is particularly well exemplified by research from
the Bucharest Early Intervention Project (www.
bucharestearlyinterventionproject.org/), which shows
that foster care can, at least partially, reverse impair-
ments in brain activity and cognition suffered by
orphaned children (Smyke et al. 2010, Vanderwert
et al. 2010, Fox et al. 2011, Sheridan et al. 2012, also
see Rutter & O’Connor 2004). Moreover, our own
studies have shown spontaneous recovery from stress-
induced neuromorphological and behavioural changes
in the rat brain (Sousa & Almeida 2012) and pharma-
cological correction of early life stress (ELS)-induced
alterations in neuroendocrine, emotional and cognitive
impairments in mice (Murgatroyd et al. 2009). The
ability to effectively alter environment-triggered altera-
tions in brain structure and function most likely
depends on the quality, magnitude and duration of
the initial ‘insult’ as well as on the exploitation of crit-
ical ‘windows of interventional opportunity’.
The present review focuses on the epigenetic regu-
lation of gene expression by ELS and its role in
establishing neuroendocrine and behavioural pheno-
types relevant to neuropsychiatric conditions. There
are now strong links between stress (acute and accu-
mulated) and disorders of cognition, mood and affect
(Holsboer & Ising 2010, Sousa & Almeida 2012),
and drug and alcohol abuse (Rodrigues et al. 2011);
further, stress (and depression) is thought to predis-
pose individuals to Alzheimer’s disease (Sotiropoulos
et al. 2011). In addition, stress is causally linked to
metabolic disorders, such as overweight, obesity and
diabetes (Noll et al. 2007, Scott et al. 2008,
Kivim€aki et al. 2011); on the one hand, these condi-
tions are considered to be important risk factors for
disturbances in mood, affect and cognition (Noll
et al. 2007, Scott et al. 2008, Xu et al. 2011), and
on the other hand, they may influence the efficacy of
pharmacotherapies for certain brain disorders (Kloi-
ber et al. 2007). Some of the best illustrations of
how lifelong energy homoeostasis and susceptibility
to metabolic and cardiac disease are programmed by
the intra-uterine environment and comes from studies
on foetal nutrition (Kyle & Pichard 2006, Wells
2007, Gluckman 2011, Lillycrop & Burdge 2011).
Increased glucocorticoid (GC) secretion is a key
physiological response to stress. This response nor-
mally serves to restore physiological and behavioural
homoeostasis through actions in a variety of cells, tis-
sues and organs, including the brain. As their name
implies, a major role of GC is to regulate energy
(glucose) mobilization with concomitant increases
in insulin secretion during stressful periods; their
contribution to the adaptive response to stress
includes suppression of immune and reproductive
functions and increased cardiac output and blood sup-
ply to essential central and peripheral tissues (Selye
1998), as well as a diverse set of behavioural changes
(e.g. hyperarousal and recall of contextual memories).
However, the adaptation-promoting actions of GC
can become deleterious for the organism when the
regulatory mechanisms that operate to eventually
restrain GC secretion go awry, especially when the
type, strength or duration of the stressor exceeds
certain thresholds.
Persistent GC hypersecretion may be considered as
‘malprogramming’ insofar that the rheostatic mecha-
nisms that regulate the quality and magnitude of
neuroendocrine responses (and subsequently, physio-
logical, metabolic and behavioural responses) become
dysregulated and compromise health and future adap-
tation. Excess GC levels in adults have been linked
to major depression and anxiety (Holsboer & Ising
2010) and a variety of other psychiatric, metabolic
and immune disorders (Chrousos & Kino 2007,
Aguilera 2011); in addition, high levels of GC are
associated with impairments in certain cognitive
domains (Marin et al. 2011). Interestingly, both the
mood- and cognition-impairing effects of GC in
humans have been shown to be (at least transiently)
reversible after correction of the underlying endocrine
anomalies (Hook et al. 2007, Schatzberg & Lindley
2008). While the ability of GC to alter adult brain
architecture and connectivity in humans and experi-
mental animals (Marin et al. 2011, Sousa & Almeida
2012) is established, the influence of adverse early life
experiences (and early life exposure to GC) on lifelong
dysregulation of behavioural and GC secretion has
only relatively recently become a major area of
research.
Prenatal stress and GC exposure
Being small, lipophilic molecules, GC can readily tra-
verse the placental barrier and influence brain devel-
opment in utero, placing the foetuses of stressed
mothers at special risk. Also at risk, are the offspring
of women at risk of premature delivery because these
subjects often receive GC therapy to accelerate matu-
ration of the foetal lung (Hallman et al. 2010). The
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placenta has its own protective mechanism to reduce
GC load on the foetus; it expresses high levels of
the enzyme 11b-hydroxysteroid dehydrogenase 2
(11b-HSD2), which converts active endogenous
GC (cortisol and corticosterone) into inactive metabo-
lites (cortisone and 11b-dehydrocorticosterone) that
cannot activate glucocorticoid receptors (GR; Wyrwoll
et al. 2011) (synthetic GCs, such as dexamethasone,
that are used for therapeutic purposes are, however,
not 11b-HSD2 substrates). Interestingly, 11b-HSD2 is
also expressed in the brain, including areas involved
in the control of emotion and cognition (Wyrwoll
et al. 2011), thus serving as an additional protective
gate against elevated GC levels.
The brain programming potential of prenatal GC
exposure was recently reviewed by us (Mesquita et al.
2009, Rodrigues et al. 2011). We previously showed
that treatment of rat dams with dexamethasone
during the last trimester of pregnancy results in off-
spring that have a marked anxious phenotype (Olive-
ira et al. 2006). We also found that intra-uterine
exposure to dexamethasone reduces the number of
dopamine-producing cells and dopaminergic tone in
the mesolimbic (ventral tegmentum–nucleus accum-
bens, VTA-NAc) reward pathway, with a significant
reduction in the volume of NAc dendrites (Le~ao et al.
2007). Behavioural correlates of these neuromorpho-
chemical changes were subsequently found: antenatal
dexamethasone-treated animals displayed greater sen-
sitivity to the psychostimulatory actions of the opiate
morphine and increased preference for alcohol and
morphine (drug-seeking phenotype) when tested as
adults (Rodrigues et al. 2012). Molecular analyses
carried out in the same study identified an epigenetic
basis for these observations. Specifically, they revealed
that prenatal dexamethasone leads to abnormal meth-
ylation of regulatory regions of the gene encoding the
dopamine receptor (Drd2) and increased mRNA levels
of Drd2 in the NAc. The latter was down-regulated
after repeated administration of morphine, with paral-
lel increases in methylation of the Drd2 promoter.
Further, administration of L-DOPA, a substrate for
dopamine synthesis, normalized the hypodopaminergic
state, methylation of the Drd2 promoter, restored
dendritic arborization in the NAc and reversed the
drug-seeking behaviour shown by these animals. These
findings show how GC pharmacotherapy in early life
programs a particular behaviour (drug-seeking), a con-
dition that frequently accompanies mood and affective
disorders in humans.
The question of how prenatal stress or GC accesses
the brain was recently addressed in an important
paper, which showed that restraint stress during preg-
nancy in rats leads to concomitant decreases in pla-
cental expression of 11b-Hsd2 (associated with
increased DNA methylation at specific CpG sites
within the HSD11b2 promoter) and increases in DNA
methyltransferase 3a mRNA (Jensen Pe~na et al.
2012). In humans, maternal GC levels correlate with
those found in the foetus (Gitau et al. 1998), indicat-
ing that the placental barrier can be breached with
implications for the development of psychopathology
in the offspring. A recent study reported heightened
endocrine responses to stress and depressive-like
behaviour in the male offspring of mouse dams that
experienced stress during early gestation (before the
presence of a foetal brain); this phenotype was charac-
terized by increased expression of the gene encoding
corticotrophin-releasing hormone (Crh, a neuropeptide
responsible for driving GC secretion), correlating with
reduced methylation of the Crh promoter (Mueller &
Bale 2008). Jensen Pe~na et al. (2012) noted that
maladaptive behaviours in the offspring of mothers
experiencing high GC levels during pregnancy may be
viewed as the cost of survival. At this juncture, it
deserves mention that, as Seymour Levine, a pioneer
of this aspect of developmental psychobiology,
observed, certain stress paradigms may actually evoke
‘positive’ effects (Levine 1957). For example, mild GC
elevations during prenatal and neonatal life in rodents
improve cognition and emotional responses (Catalani
et al. 2011) and may facilitate adaptive adjustments
to future challenges (Macrı et al. 2011). These ideas
may be fundamental to understanding the origins of
individual differences in resisting stress-related psycho-
logical and somatic disease (see Levine 2005).
Early postnatal programming
Primates and rodents are altricial species, so survival of
their young depends on parental (usually, maternal)
provision of nutrients and water, hygiene/grooming,
warmth and protection from other inclement environ-
mental factors, including predators. Neglect during
childhood is known to have detrimental effects on over-
all neurodevelopment and brain structure (Kaufman &
Charney 2001, Hedges & Woon 2011, Cisler et al.
2013) and is strongly associated with psychiatric disor-
ders such as depression, post-traumatic disorder and
schizophrenia (Morgan & Fisher 2007, Heim & Binder
2012). A series of pioneering studies in rats by Michael
Meaney’s group reported that the offspring of dams
showing higher levels of maternal care (licking and
grooming) develop into adults with lower endocrine
(GC) responses to stress, as compared to the offspring
of mothers that display less intense maternal behaviour
(for review, see Zhang et al. 2013). The former off-
spring also showed higher levels of expression of hippo-
campal GR and, subsequently, faster ‘shut off’ of the
endocrine response to stress and reduced hypothalamic
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Crh mRNA expression, both reflecting superior GC
negative feedback regulation. Cross-fostering studies
suggested that epigenetic mechanisms might be respon-
sible for the observed phenotype, a view upheld by the
discovery of differential histone acetylation and DNA
methylation of a specific exon in the GR promoter in
the hippocampi of offspring of high vs. low maternal
caregivers. The potential translational importance of
these findings is reflected in another finding from the
Meaney laboratory, which reported that suicide victims
who had experienced childhood abuse express low hip-
pocampal levels of GR mRNA in association with
increased methylation of the GR promoter (McGowan
et al. 2009).
Our laboratory employs a different ELS paradigm
in mice (C57/Bl6n strain) in an attempt to understand
the relationship between stress and psychopathology
from an epigenetic perspective (Murgatroyd et al.
2009). Our ELS protocol involves daily separation
(3 h, variable times of the day) of mouse litters from
their dams during the first ten postnatal days, leading
to characteristic endocrine and behavioural pheno-
types in adulthood. Specifically, male ELS-exposed
mice display learned helplessness (immobility) in the
forced swim test and impaired spatial and fear-condi-
tioned learning. At the same time, ELS-treated mice
have elevated GC levels under baseline conditions
and show stress-induced GC secretory responses that
are exaggerated in terms of magnitude and duration
(indicating impaired GC negative feedback in the
brain and pituitary and/or hyperactivation of the
hypothalamic neurones responsible for positive regu-
lation of GC secretion). Following a candidate gene
approach, we searched for epigenetic modifications in
a number of genes in the limbic–hypothalamic–pitui-
tary circuitry that are known to be important for reg-
ulation of GC secretion. Among others, this analysis
revealed hypomethylation of the so-called enhancer
region of Avp, the gene that encodes arginine vaso-
pressin (Avp), a hypothalamic neuropeptide that,
under sustained demand (e.g. chronic stress or adre-
nalectomy), plays a critical role in ensuring higher
corticotrope–GC output (Tilders et al. 1985, Davis
et al. 1986, Hellbach et al. 1998). Consistent with
our demonstration that this hypomethylation resulted
in attenuated binding of methyl CpG-binding protein
2 (Mecp2) to the Avp enhancer (Mecp2 serves as a
scaffold for the assembly of repressor complexes
including histone deacetylases and DNA meth-
yltransferases), we observed an up-regulation of Avp
mRNA expression (Murgatroyd et al. 2009). Further
analysis revealed that ELS-induced DNA hypomethy-
lation is preceded by loss of Mecp2 occupancy during
early life; the latter event depends on activity-driven
phosphorylation of Mecp2 through the mediation of
Ca2+-/calmodulin-dependent protein kinase II (CaM-
KII). The observation that loss of Mecp2 occupancy
requires neural activity is important: it dismisses a
role for GC in the mechanisms leading to hypome-
thylation of the Avp enhancer. In fact, the rodent
adrenal first produces detectable levels of GC from
about postnatal day 14; until this age, rodents are
considered to be ‘stress-hyporesponsive’ (Sapolsky &
Meaney 1986) even though they can emit ultrasonic
calls (Hofer 1996) and release catecholamines (Sulli-
van 2003) from birth.
The above-reported molecular and endocrine
responses induced by ELS were first seen at day 10 of
life (at the end of the ELS paradigm) and were detect-
able for at least 1 year (Murgatroyd et al. 2009).
Without necessarily excluding other mechanisms,
these sustained changes in endocrine and behavioural
function can be largely attributed to ELS-induced
modifications in Avp expression because the pheno-
type was reversible with an AVP receptor antagonist
(Murgatroyd et al. 2009). Another interesting aspect
of this study is that the epigenetic changes observed
occurred in (presumably) postmitotic neurones;
although neurogenesis has been described in certain
hypothalamic nuclei, the parvocellular paraventricular
nucleus, in which the AVP neurones of interest to this
work are located, is not known to be a neuroprolifera-
tive zone.
The peripubertal window – adolescent
obesity and adult behaviour
Body mass and adiposity in childhood and adoles-
cence appear to be good predictors of risk of obesity
in adulthood. Comorbidity of adult overweight and
depression and anxiety disorders occurs frequently
(especially among women), with clinical evidence
pointing to bilateral interactions between weight and
mood/emotional states during adolescence and adult-
hood (Heo et al. 2006, Noll et al. 2007, Strine et al.
2008, Wouters et al. 2011). A number of interacting
intra- and interdomain factors are likely to contribute
to the final behavioural and metabolic phenotype,
including psychological (e.g. family/social stability,
self-esteem, dissatisfaction with body image, stigmati-
zation, role models, motivation, behavioural control),
physiological (e.g. multiple endocrine factors, includ-
ing insulin, leptin, GC, sex steroids; energy absorption
and utilization) and environmental (e.g. peer pressure,
promotional media, physical activity, socio-economic
circumstances) (Bornstein et al. 2006, Hyde et al.
2008, Cole et al. 2012). While body mass and adipos-
ity are determined by the amount of energy consumed
and the amount of energy expended, it is interesting
that depression becomes more prevalent in girls than
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in boys around the onset of puberty (Cyranowski
et al. 2000, Angold & Costello 2006).
In a recent (unpublished) study, we examined how
transient diet-induced obesity (DIO) in peripubertal
rats influences adult behaviour in male and female rats
(from between days 21 and days 80 of life, with testing
when rats were 180 days old; see Fig. 1). Our experi-
mental design was chosen against the background that
reward (here delivered in the form of a palatable cafe-
teria-type diet) and mood are closely linked (Scott
et al. 2008, Kivim€aki et al. 2011, Dauncey 2013,
Sinha & Jastreboff 2013), with both being subject to
modulation by peripheral endocrine and metabolic
signals. The paradigm used to achieve DIO involved
giving animals a choice between standard chow and
cafeteria diet (CD) that changed on a daily basis.
While the use of CD in rodent experiments has certain
advantages over HFD (Sampey et al. 2011), the CD
approach is limited by the fact that the experimenter
does not have complete control of the composition
(individual ingredients and energy) of the food. To
increase palatability of the CD, investigators com-
monly use foods that contain animal fat products or
chocolate; we however avoided such foods for ethical
reasons as well as hygiene and reproducibility and
instead increased the incentive salience of the CD by
providing chocolate-free diets containing nuts, marzi-
pan, fruit-flavoured cereal bars and shortbread. Con-
trol animals only received standard chow.
Animals consumed high amounts of the CD,
but they nevertheless continued to consume small
amounts of the standard chow and showed rapid
body weight gain, when compared to age-matched
controls (Fig. 2a). Interestingly, when the CD was
withdrawn at the age of 80 days, female rats showed
reduced BW gain, whereas male rats continued to
show body weight increases above those seen in age-
matched control animals (Fig. 2b). Consistent with
these feeding and growth patterns, CD-exposed males
were found to have larger fat pads at necropsy
(Fig. 2c).
Behavioural phenotyping (see Sousa et al. 2006 for
methodological background) performed when animals
were approx. 180 days old (100 days after last expo-
sure to CD) revealed that the peripubertal DIO para-
digm led to alterations in anxiety- and depression-like
behaviour. Both males and females that had been
exposed to the CD during peripubertal life displayed
stronger signs of depression-like behaviour when
tested in the forced swim test (Fig. 3a). Depression
and anxiety frequently co-exist in humans, with
greater comorbidity occurring in women (Alexander
et al. 2007). We here observed, however, that whereas
CD-exposed males were significantly more anxious
than their age-matched controls in two different
behavioural assays (open arena and an elevated plus
maze), CD-exposed females were, if anything, less
anxious than their corresponding controls (Fig. 3b).
As mentioned earlier, there are strong correlations
between stress, GC levels and mood and emotional
behaviour (Holsboer & Ising 2010). In view of
this, we also examined GC levels in control and
CD-exposed rats at the age of 180 days. Surprisingly,
no differences were observed in daytime (nadir) and
night-time (peak) GC levels when control and
CD-treated male rats were compared (Fig. 4a). As
expected, control female rats displayed higher levels
of GC secretion than males (both time points)
(Fig. 4a). Daytime and night-time GC levels were sig-
nificantly higher in CD-exposed females as compared
to their corresponding standard diet-fed controls
(Fig. 4a). The latter results were supported by mea-
sures of GR mRNA expression in the hippocampus, a
key brain area involved in the mediation of GC nega-
tive feedback: as shown in Figure 4b, the CD-exposed
females were the only group to exhibit any treatment-
related changes (decreases) in hippocampal GR
expression. Lastly, the female CD-treated rats stood
out from among the other experimental groups in that
they showed the largest GC secretory response to an
acute stressor (at 30 min). The above-reported
data suggest that CD exposure during peripubertal
Age
0 20 40 60 80 100 180 days
DIO Standard chow
HPA-profile
Behavioral phenotyping
Figure 1 Experimental protocol used to examine the influence of diet-induced obesity (DIO) on activity of the hypothalamo–
pituitary–adrenal (HPA) axis and depression-like and anxiety-related behaviour in rats. Male and female Wistar rats were
weaned on postnatal day 21 and maintained under standard laboratory conditions. Animals were provided ad libitum with
either standard laboratory chow (controls) or a cafeteria diet (CD) from days 21 to 80 of life to induce peripubertal DIO
(ppDIO). From day 80 onwards, all animals were kept on standard laboratory chow. On postnatal day 180 (100 days after
withdrawal of the CD), animals were successively tested for anxiety-related and depression-like behaviours (using the elevated
plus maze test and forced swim test, respectively) and HPA axis activity under basal and acute stress (2-min air puff) conditions.
There was an interval of 1 week between each of the tests.
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development leads to sex-specific disruption of the
normal processes regulating GC secretion under basal
and stressful conditions and a dissociation of GC
secretory levels from the expression of depression- and
anxiety-like behaviours.
Back to the future
Life events clearly influence physiological and behavio-
ural trajectories. As reviewed here, early life experiences
exert their effects, at least in part, through epigenetic
mechanisms that lead to long-term changes in gene
expression potential and, as has been recognized for
decades, the brain is accessible to environment-induced
(a)
(b)
(c)
Figure 2 Body weight changes and visceral fat mass. (a) Male
and female rats with access to cafeteria diet (ppDIO) from days
21 to 80 of life displayed gained body weight gains that were
significantly greater than chow-fed controls (P ≤ 0.05). (b) A
small (non-significant) increase in body weight was observed in
ppDIO males that were returned to standard chow between the
ages of 80 and 180 days; in contrast, similarly treated females
showed a small but significant slowdown of weight gain
(P ≤ 0.05). (c) Although ppDIO males that were returned to
standard chow between the ages of 80 and 180 did not show
weight gain, they displayed a significantly higher mass of visceral
fat (P ≤ 0.05). All values shown are mean  SEM (n = 5–7 per
group). Asterisks indicate P < 0.05 (t-test comparisons of same-
sex groups). ppDIO, peripubertal diet-induced obesity.
(a)
(b)
Figure 3 Behavioural phenotype of rats with a history of
peripubertal diet-induced obesity (ppDIO). (a) Both male and
female rats with a history of ppDIO showed significantly
increased immobility in the forced swim test, a measure of
depression-like behaviour (P ≤ 0.05). The forced swim test
was performed during the dark phase of the daily light–dark
cycle, on two consecutive days. On the first day, the test
lasted 15 min; on the second day, the test was 5 min long,
and only data from this second session were video-recorded
and subsequently quantified; time spent immobile (floating) is
shown as a percentage of total time (5 min) in the test appa-
ratus. (b) As compared to ppDIO females, ppDIO males dis-
played significantly higher (P ≤ 0.05) levels of anxiety-related
behaviour in the elevated plus maze (EPM), as measured by
the percentage of time they spent exploring the open arms of
the maze. Data shown are mean  SEM (n = 5–7 per group).
Asterisks indicate P < 0.05 (t-test comparisons of same-sex
groups).
© 2013 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12140 7
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plasticity from very early gestation through to puberty.
Obviously, much still remains to be done in order to
identify those external stimuli that have the greatest
impact on any given function of interest, as well as to
assess to what extent that stimulus alters quality of life.
Survival is ensured by dynamic adaptations at the
multilayered levels of organization and regulation of
physiological processes; it will be therefore important
to know the extent of ‘permanency’ of the snapshot
phenotypes that we and others have recorded to date.
Growing acceptance of the view that even DNA meth-
ylation may not result in indelible epigenetic marks
(Metivier et al. 2008, Ma et al. 2009, Lee et al. 2010,
Guo et al. 2011a,b, Unternaehrer et al. 2012) prompts
the question of how different signals arriving at inter-
vals over lifetime act on the pre-existing epigenome to
(re)shape the next phase of life. This necessarily
includes definition of the spectrum of windows that
may be accessible to epigenetic modification; it may
be too early to exclude that these can open, narrow,
close and even re-open in cell-, network- and environ-
ment-specific ways (Fig. 5). Keeping an open mind to
these possibilities will not only help physiologists to
appreciate the full potential of the brain’s plasticity
but may also provide biological explanations for how
otherwise fixed programs become reversible through
social, psychological and pharmacological interven-
tions, some examples of which were given earlier in
this article.
Epigenetic mechanisms bring a promising and excit-
ing new perspective to the physiologist’s quest to
comprehend the complex systems as well as their inte-
gration that result in coordinated responses to internal
and external demands. Remembering Leonardo da
(a)
(b)
Figure 4 Peripubertal diet-induced obesity (ppDIO) effects
on regulation of hypothalamo–pituitary–adrenal (HPA) axis
activity. (a) Activity of the HPA axis was assessed under
basal (resting) conditions during the daily zenith and nadir of
corticosterone (CORT) secretion, as well as 30 or 120 min
after exposure to an acute (air puff) stressor. Serum CORT
was measured using a commercial radioimmunoassay kit
(MP Biochemicals, Costa Mesa, CA, USA). Data show that
ppDIO blunts the circadian fluctuations in HPA axis activity
in female, but not in male, rats (P ≤ 0.05). Further, ppDIO
rats showed an exaggerated response to acute stress. (b)
Shows results of semiquantitative in situ hybridization analy-
sis of glucocorticoid receptor (GR) mRNA expression in the
dentate gyrus of the hippocampal formation. There was a
significant down-regulation of GR mRNA in ppDIO females
(P ≤ 0.05). All data are shown mean  SEM (n = 5–7 per
group). Asterisks indicate P < 0.05 (t-test comparisons of
same-sex groups).
Figure 5 Maintenance of physiological and behavioural
homoeostasis during different phases of the lifespan. Lifetime
events (e.g. stress, altered nutrition) can act directly (and rap-
idly) on genetically determined physiological switches, but
may also induce epigenetic changes in varying degrees of per-
manency (not shown). As indicated by the decreasing inten-
sity of shading of the ‘programmability’ curve, from prenatal
to very old ages, it is thought that the brain of young individ-
uals is more amenable to programming (epigenetic or other-
wise) than that of older individuals. The schema shows that
older subjects will have experienced more life events (positive
and negative; note the increasing shading intensity of the
‘lifetime events’ curve, from prenatal to very old ages) that
will serve as a ‘reference library’ for responding to future
demands. This cumulative experience, ‘archived’ in previ-
ously adjusted physiological switches or epigenetic modifica-
tions, will play a decisive role in whether a subject ages
healthily or unhealthily.
© 2013 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd, doi: 10.1111/apha.121408
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Vinci’s adage ‘Simplicity is the ultimate sophistication’
may be useful in designing future experiments to
examine gene 9 environment interactions in the con-
text of behavioural or psychiatric disorders; by defini-
tion, these disorders are complex as they involve
interplay between different neural networks that are
themselves subject to local regulation and modulation.
Standardizing animal models and molecular and phe-
notypic analyses and being aware that a behaviour is
unlikely to depend on a single gene or brain region
may help us reach our goal more effectively. More-
over, biomedical experimentalists need to exert more
care in extrapolating findings in model organisms to
humans. As recently demonstrated in the context of
modelling human psychiatric disease in animals, the
impact of a given environmental stimulus may depend
heavily upon predisposing genetic risks (Niwa et al.
2013). Interpretation of many of the animal studies
discussed in this article is based on anthropomor-
phism; thus, extrapolations from experiments in
animal models of disease to psychopathological condi-
tions in humans require a certain degree of caution
(see Seok et al. 2013). On the other hand, given that
many molecular pathways and mechanisms are con-
served across species, animal research undoubtedly
serves to advance our understanding of complex
behaviours, with further advances expected as inves-
tigators refine their models. Moreover, although
developments in computational neuroscience and
sophisticated minimally invasive neurotechnologies
will facilitate exploration of the intricate circuitries
that regulate human behaviour, the molecular dissec-
tion of normal and pathological human behaviour
remains a long shot, not least because of safety and
ethical considerations.
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